| Literature DB >> 32427033 |
Alain Van Gool1, Fernado Corrales2, Mirjana Čolović3, Danijela Krstić4, Begona Oliver-Martos5, Eva Martínez-Cáceres6, Ivone Jakasa7, Goran Gajski8, Virginie Brun9, Kyriacos Kyriacou10, Izabela Burzynska-Pedziwiatr11, Lucyna Alicja Wozniak11, Stephan Nierkens12, César Pascual García13, Jaroslav Katrlik14, Zanka Bojic-Trbojevic15, Jan Vacek16, Alicia Llorente17, Felicia Antohe18, Viorel Suica18, Guillaume Suarez19, Ruben t'Kindt20, Petra Martin21, Deborah Penque22, Ines Lanca Martins22, Ede Bodoki23, Bogdan-Cezar Iacob23, Eda Aydindogan24, Suna Timur25, John Allinson26, Christopher Sutton27, Theo Luider28, Saara Wittfooth29, Marei Sammar30.
Abstract
INTRODUCTION: The importance of biomarkers for pharmaceutical drug development and clinical diagnostics is more significant than ever in the current shift toward personalized medicine. Biomarkers have taken a central position either as companion markers to support drug development and patient selection, or as indicators aiming to detect the earliest perturbations indicative of disease, minimizing therapeutic intervention or even enabling disease reversal. Protein biomarkers are of particular interest given their central role in biochemical pathways. Hence, capabilities to analyze multiple protein biomarkers in one assay are highly interesting for biomedical research. AREAS COVERED: We here review multiple methods that are suitable for robust, high throughput, standardized, and affordable analysis of protein biomarkers in a multiplex format. We describe innovative developments in immunoassays, the vanguard of methods in clinical laboratories, and mass spectrometry, increasingly implemented for protein biomarker analysis. Moreover, emerging techniques are discussed with potentially improved protein capture, separation, and detection that will further boost multiplex analyses. EXPERT COMMENTARY: The development of clinically applied multiplex protein biomarker assays is essential as multi-protein signatures provide more comprehensive information about biological systems than single biomarkers, leading to improved insights in mechanisms of disease, diagnostics, and the effect of personalized medicine.Entities:
Keywords: Multiplexing; mass spectrometry; validation
Mesh:
Substances:
Year: 2020 PMID: 32427033 DOI: 10.1080/14789450.2020.1763174
Source DB: PubMed Journal: Expert Rev Proteomics ISSN: 1478-9450 Impact factor: 3.940